APP and Alzheimer disease: Some of the APP translational modulators include 4-(5-methyl-1H-benzimidazol-2-yl) aniline (JTR-009), 2-[(pyridine-2-ylmethyl)-amino]-phenol (2-PMAP), and posiphen, which have been developed for the treatment of AD [12].